
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice
Lucy Golden‐Mason, Rachel H. McMahan, Michael Strong, et al.
Journal of Virology (2013) Vol. 87, Iss. 9, pp. 4835-4845
Open Access | Times Cited: 118
Lucy Golden‐Mason, Rachel H. McMahan, Michael Strong, et al.
Journal of Virology (2013) Vol. 87, Iss. 9, pp. 4835-4845
Open Access | Times Cited: 118
Showing 1-25 of 118 citing articles:
NK Cell-Based Immune Checkpoint Inhibition
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 277
Muhammad Khan, Sumbal Arooj, Hua Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 277
The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
Isabel Gonçalves Silva, Inna M. Yasinska, Svetlana Sakhnevych, et al.
EBioMedicine (2017) Vol. 22, pp. 44-57
Open Access | Times Cited: 191
Isabel Gonçalves Silva, Inna M. Yasinska, Svetlana Sakhnevych, et al.
EBioMedicine (2017) Vol. 22, pp. 44-57
Open Access | Times Cited: 191
Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis
Joana G. Rodrigues, Meritxell Balmaña, Joana A. Macedo, et al.
Cellular Immunology (2018) Vol. 333, pp. 46-57
Open Access | Times Cited: 191
Joana G. Rodrigues, Meritxell Balmaña, Joana A. Macedo, et al.
Cellular Immunology (2018) Vol. 333, pp. 46-57
Open Access | Times Cited: 191
Galectin-9 as a biomarker of disease severity
Preeti Moar, Ravi Tandon
Cellular Immunology (2021) Vol. 361, pp. 104287-104287
Closed Access | Times Cited: 108
Preeti Moar, Ravi Tandon
Cellular Immunology (2021) Vol. 361, pp. 104287-104287
Closed Access | Times Cited: 108
The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity
Joanna Bagińska, Elodie Viry, Jérôme Paggetti, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 177
Joanna Bagińska, Elodie Viry, Jérôme Paggetti, et al.
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 177
Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis
Santiago P. Méndez‐Huergo, Ada G. Blidner, Gabriel A. Rabinovich
Current Opinion in Immunology (2017) Vol. 45, pp. 8-15
Closed Access | Times Cited: 138
Santiago P. Méndez‐Huergo, Ada G. Blidner, Gabriel A. Rabinovich
Current Opinion in Immunology (2017) Vol. 45, pp. 8-15
Closed Access | Times Cited: 138
Evolving Mechanistic Insights into Galectin Functions
Connie M. Arthur, Marcelo Dias‐Baruffi, Richard D. Cummings, et al.
Methods in molecular biology (2014), pp. 1-35
Open Access | Times Cited: 117
Connie M. Arthur, Marcelo Dias‐Baruffi, Richard D. Cummings, et al.
Methods in molecular biology (2014), pp. 1-35
Open Access | Times Cited: 117
Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
Shravan Madireddi, So-Young Eun, Seung‐Woo Lee, et al.
The Journal of Experimental Medicine (2014) Vol. 211, Iss. 7, pp. 1433-1448
Open Access | Times Cited: 116
Shravan Madireddi, So-Young Eun, Seung‐Woo Lee, et al.
The Journal of Experimental Medicine (2014) Vol. 211, Iss. 7, pp. 1433-1448
Open Access | Times Cited: 116
Translating the ‘Sugar Code’ into Immune and Vascular Signaling Programs
Juan P. Cerliani, Ada G. Blidner, Marta A. Toscano, et al.
Trends in Biochemical Sciences (2016) Vol. 42, Iss. 4, pp. 255-273
Open Access | Times Cited: 107
Juan P. Cerliani, Ada G. Blidner, Marta A. Toscano, et al.
Trends in Biochemical Sciences (2016) Vol. 42, Iss. 4, pp. 255-273
Open Access | Times Cited: 107
Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
Nayoung Kim, Hun Sik Kim
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 103
Nayoung Kim, Hun Sik Kim
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 103
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Laura Chiossone, Margaux Vienne, Yann M. Kerdiles, et al.
Seminars in Immunology (2017) Vol. 31, pp. 55-63
Closed Access | Times Cited: 100
Laura Chiossone, Margaux Vienne, Yann M. Kerdiles, et al.
Seminars in Immunology (2017) Vol. 31, pp. 55-63
Closed Access | Times Cited: 100
Cancer Extracellular Matrix Proteins Regulate Tumour Immunity
Alex Gordon‐Weeks, Arseniy E. Yuzhalin
Cancers (2020) Vol. 12, Iss. 11, pp. 3331-3331
Open Access | Times Cited: 87
Alex Gordon‐Weeks, Arseniy E. Yuzhalin
Cancers (2020) Vol. 12, Iss. 11, pp. 3331-3331
Open Access | Times Cited: 87
Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity
Inna M. Yasinska, N. Helge Meyer, Stephanie Schlichtner, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 79
Inna M. Yasinska, N. Helge Meyer, Stephanie Schlichtner, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 79
Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
Chuan-Xia Zhang, Dai-jia Huang, Valentin Baloche, et al.
Oncogenesis (2020) Vol. 9, Iss. 7
Open Access | Times Cited: 72
Chuan-Xia Zhang, Dai-jia Huang, Valentin Baloche, et al.
Oncogenesis (2020) Vol. 9, Iss. 7
Open Access | Times Cited: 72
Galectin-9 promotes natural killer cells activity via interaction with CD44
Amirhossein Rahmati, Steven Bigam, Shokrollah Elahi
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Amirhossein Rahmati, Steven Bigam, Shokrollah Elahi
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Mitofusin 1 silencing decreases the senescent associated secretory phenotype, promotes immune cell recruitment and delays melanoma tumor growth after chemotherapy
Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Doménica Tarallo, Jennyfer Martínez, Alejandro Leyva, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells
Yunjia Dong, Anqi Cheng, Jiawei Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Yunjia Dong, Anqi Cheng, Jiawei Zhou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Emerging concepts in immunity to hepatitis C virus infection
Hugo R. Rosen
Journal of Clinical Investigation (2013) Vol. 123, Iss. 10, pp. 4121-4130
Open Access | Times Cited: 90
Hugo R. Rosen
Journal of Clinical Investigation (2013) Vol. 123, Iss. 10, pp. 4121-4130
Open Access | Times Cited: 90
The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections
Shahzma Merani, Wenna Chen, Shokrollah Elahi
Reviews in Medical Virology (2015) Vol. 25, Iss. 3, pp. 175-186
Closed Access | Times Cited: 83
Shahzma Merani, Wenna Chen, Shokrollah Elahi
Reviews in Medical Virology (2015) Vol. 25, Iss. 3, pp. 175-186
Closed Access | Times Cited: 83
Peripheral Blood TIM-3 Positive NK and CD8+ T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy
Mátyás Meggyes, Éva Mikó, Beata Polgár, et al.
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e92371-e92371
Open Access | Times Cited: 83
Mátyás Meggyes, Éva Mikó, Beata Polgár, et al.
PLoS ONE (2014) Vol. 9, Iss. 3, pp. e92371-e92371
Open Access | Times Cited: 83
Galectin‐9: Diverse roles in hepatic immune homeostasis and inflammation
Lucy Golden‐Mason, Hugo R. Rosen
Hepatology (2017) Vol. 66, Iss. 1, pp. 271-279
Open Access | Times Cited: 69
Lucy Golden‐Mason, Hugo R. Rosen
Hepatology (2017) Vol. 66, Iss. 1, pp. 271-279
Open Access | Times Cited: 69
Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models
Sujogya Kumar Panda, Valeria Facchinetti, Elisaveta Voynova, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 5, pp. 1873-1887
Open Access | Times Cited: 61
Sujogya Kumar Panda, Valeria Facchinetti, Elisaveta Voynova, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 5, pp. 1873-1887
Open Access | Times Cited: 61
Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
Gustavo Rodrigues Rossi, Edvaldo da Silva Trindade, Fernando Souza‐Fonseca‐Guimaraes
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
Gustavo Rodrigues Rossi, Edvaldo da Silva Trindade, Fernando Souza‐Fonseca‐Guimaraes
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 56
Emerging Immunotherapy for Acute Myeloid Leukemia
Rikako Tabata, SungGi Chi, Junichiro Yuda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1944-1944
Open Access | Times Cited: 49
Rikako Tabata, SungGi Chi, Junichiro Yuda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1944-1944
Open Access | Times Cited: 49
Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer
Qi Zhang, Yezhen Tan, Jianye Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Qi Zhang, Yezhen Tan, Jianye Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29